Shiga toxin/verotoxin-producing Escherichia coli in humans, food and animals in the EU/EEA, with special reference to the German outbreak strain STEC O104
This joint report, produced by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA), aims to give a short summary of reported Shiga toxin/verotoxin-producing Escherichia coli (STEC/VTEC) prevalence and incidence in humans, food and animals.
West Nile virus risk assessment tool
West Nile virus (WNV) is an emerging pathogen whose ecology and epidemiology extend across multiple interfaces. As the epidemiology and transmission cycle of WNV is complex, assessing the risk of WNV being transmitted to humans is not always straightforward. Therefore, the WNV risk assessment tool has been developed to provide operational guidance in support of the risk assessment process.
Avian influenza A/H5N1: Collected risk assessments, technical guidance to public health authorities and advice to the general public
The document determines the risk to human health in Europe from highly pathogenic avian influenza viruses in birds and animals and identifies areas requiring additional scientific and public health work both as single pieces of work and for risk monitoring by ECDC and its partners.
Synergies in community and institutional public health emergency preparedness for tick-borne diseases in Spain
The present report is concerned with the events in Spain surrounding two cases of infection with Crimean-Congo Haemorrhagic Fever (CCHF) virus that emerged in the Autonomous Community of Castilla y León in August 2016.
Synergies in community and institutional public health emergency preparedness for tick-borne diseases in the Netherlands
The present report is concerned with the emerging infection of tick-borne encephalitis in the Netherlands — the two first endemic cases occurring in July 2016 — in the larger context of a widespread and increasing incidence of lyme borreliosis.
An overview of the rapid test situation for COVID-19 diagnosis in the EU/EEA
According to EU recommendations, timely and accurate COVID-19 laboratory testing is an essential part of the management of COVID-19 for slowing down the pandemic, supporting decisions on infection control strategies and patient management at healthcare facilities, and detecting asymptomatic cases that could spread the virus further if not isolated.
Guidance for wearing and removing personal protective equipment in healthcare settings for the care of patients with suspected or confirmed COVID-19
This document provides support to healthcare workers when managing suspected or confirmed cases of novel coronavirus 2019 (COVID-19). Available in 26 languages.
Strategies for the surveillance of COVID-19
This document proposes an updated strategy for COVID-19 surveillance at national and EU/EEA level that specifically aims to reconcile the data needs for effective pandemic response with what is still feasible in countries and within healthcare systems under siege, while taking into account guidance issued by the World Health Organization.
Considerations relating to passenger locator data, entry and exit screening and health declarations in the context of COVID-19 in the EU/EEA and the UK
The scope of this document is to provide ECDC’s views on the passenger locator data required and the appropriate use of entry and exit screening procedures at points of entry (PoE), including health declaration forms, in the context of COVID-19 in the EU/EEA and the United Kingdom (UK).
Use of gloves in healthcare and non-healthcare settings in the context of the COVID 19 pandemic
This document aims to provide scientific evidence and guidance for healthcare settings and the public on using gloves as a preventive measure during the COVID-19 pandemic.